Development of degeneration contraction and supersensitivity in the cat's nictitating membrane after 6-hydroxydopamine.
D000643:Ammonium Chloride / Q000494:pharmacology; D000818:Animals; D002415:Cats; D004298:Dopamine / Q000494:pharmacology*; D005260:Female; D007279:Injections, Subcutaneous; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009121:Muscle Denervation; D009541:Nictitating Membrane / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology
D000643:Ammonium Chloride; D012110:Reserpine; D010293:Pargyline; D004298:Dopamine; D009638:Norepinephrine